TY - JOUR
T1 - An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011
AU - Bowring, Anna L
AU - Luhmann, Niklas
AU - Pont, Sandrine
AU - Debaulieu, Celine
AU - Derozier, Stephanie
AU - Asouab, Fatima
AU - Toufik, Abdalla
AU - Van Gemert, Caroline
AU - Dietze, Paul Mark
AU - Stoove, Mark
PY - 2013
Y1 - 2013
N2 - Background: Injecting drug use (IDU) is a growing concern in Tanzania compounded by reports of high-risk injecting and sexual risk behaviours among people who inject drugs (PWID). These behaviours have implications for transmission of blood-borne viruses, including HIV and hepatitis C (HCV). Methods: We recruited 267 PWID (87 male) from Temeke District, Dar-es-Salaam through snowball and targeted sampling. A behavioural survey was administered alongside repeated rapid HIV and HCV antibody testing. HIV and HCV prevalence estimates with 95 confidence intervals (CIs) were calculated. Results: Among PWID, 34.8 (95 CI 29.1-40.9) tested HIV positive (29.9 of males and 66.7 of females); 27.7 (95 CI 22.0-34.0) tested HCV antibody positive. Almost all (97 ) participants were aware of HIV and 34 of HCV. 45 of male and 64 of female PWID reported a previous HIV test; only five (2 ) PWID reported a previous HCV test. Of HIV and HCV positive tests, 73 and 99 , respectively, represented newly diagnosed infections. Conclusion: High prevalence of HIV and HCV were detected in this population of PWID. Rapid scale-up of targeted primary prevention and testing and treatment services for PWID in Tanzania is needed to prevent further transmission and consequent morbidities.
AB - Background: Injecting drug use (IDU) is a growing concern in Tanzania compounded by reports of high-risk injecting and sexual risk behaviours among people who inject drugs (PWID). These behaviours have implications for transmission of blood-borne viruses, including HIV and hepatitis C (HCV). Methods: We recruited 267 PWID (87 male) from Temeke District, Dar-es-Salaam through snowball and targeted sampling. A behavioural survey was administered alongside repeated rapid HIV and HCV antibody testing. HIV and HCV prevalence estimates with 95 confidence intervals (CIs) were calculated. Results: Among PWID, 34.8 (95 CI 29.1-40.9) tested HIV positive (29.9 of males and 66.7 of females); 27.7 (95 CI 22.0-34.0) tested HCV antibody positive. Almost all (97 ) participants were aware of HIV and 34 of HCV. 45 of male and 64 of female PWID reported a previous HIV test; only five (2 ) PWID reported a previous HCV test. Of HIV and HCV positive tests, 73 and 99 , respectively, represented newly diagnosed infections. Conclusion: High prevalence of HIV and HCV were detected in this population of PWID. Rapid scale-up of targeted primary prevention and testing and treatment services for PWID in Tanzania is needed to prevent further transmission and consequent morbidities.
UR - http://www.sciencedirect.com/science/article/pii/S0955395912001223
U2 - 10.1016/j.drugpo.2012.08.005
DO - 10.1016/j.drugpo.2012.08.005
M3 - Article
VL - 24
SP - 78
EP - 81
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
SN - 0955-3959
IS - 1
ER -